Delivery Order SPE2DB22D1106-SPE2DB24FEAD1
Award Date 2/13/24
Potential Completion Date 3/6/24
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $10,485.00 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,496,211 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,982 units of the pharmaceutical product XEOMIN 100 Unit Vials. The contract has a potential value of $7,715.88 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,145.50 to the Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 4564421570 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and an ultimate completion date of May 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,850.00 firm fixed price delivery order contract to provide 50-unit vials of the pharmaceutical product XEOMIN. The contract has a completion date of March 14, 2024 and was awarded on February 22, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $12,057.69 firm fixed-price delivery order is for the supply of 4,565 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $44,036.16 contract is for the delivery of 4,563,871,394 vials of the pharmaceutical product XEOMIN 100 UNIT. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $31,454.40 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563 units of XEOMIN 100 UNIT VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities...
- The Defense Logistics Agency (DLA) has awarded a $20,970.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 4,563,759,737 units of the drug XEOMIN. This delivery order is not associated with any set-aside program and has a completion date of March 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company....
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of XEOMIN 100 unit vials. The contract, with a ceiling value of $12,319.64, is a firm fixed-price delivery order contract with a period of performance through June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEAD1Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,106.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 200 unit vials of the drug XEOMIN. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 5/14/24, 11:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 2/13/24 |